Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Oct;28(5):2072-2082.
doi: 10.1007/s12350-019-01963-x. Epub 2019 Dec 2.

Added value of 18F-FDG-PET/CT and cardiac CTA in suspected transcatheter aortic valve endocarditis

Affiliations
Multicenter Study

Added value of 18F-FDG-PET/CT and cardiac CTA in suspected transcatheter aortic valve endocarditis

Ali R Wahadat et al. J Nucl Cardiol. 2021 Oct.

Abstract

Backgrounds: Transcatheter-implanted aortic valve infective endocarditis (TAVI-IE) is difficult to diagnose when relying on the Duke Criteria. Our aim was to assess the additional diagnostic value of 18F-fluorodeoxyglucose (18F-FDG) positron emission/computed tomography (PET/CT) and cardiac computed tomography angiography (CTA) in suspected TAVI-IE.

Methods: A multicenter retrospective analysis was performed in all patients who underwent 18F-FDG-PET/CT and/or CTA with suspected TAVI-IE. Patients were first classified with Duke Criteria and after adding 18F-FDG-PET/CT and CTA, they were classified with European Society of Cardiology (ESC) criteria. The final diagnosis was determined by our Endocarditis Team based on ESC guideline recommendations.

Results: Thirty patients with suspected TAVI-IE were included. 18F-FDG-PET/CT was performed in all patients and Cardiac CTA in 14/30. Using the Modified Duke Criteria, patients were classified as 3% rejected (1/30), 73% possible (22/30), and 23% definite (7/30) TAVI-IE. Adding 18F-FDG-PET/CT and CTA supported the reclassification of 10 of the 22 possible cases as "definite TAVI-IE" (5/22) or "rejected TAVI-IE" (5/22). This changed the final diagnosis to 20% rejected (6/30), 40% possible (12/30), and 40% definite (12/30) TAVI-IE.

Conclusions: Addition of 18F-FDG-PET/CT and/or CTA changed the final diagnosis in 33% of patients and proved to be a valuable diagnostic tool in patients with suspected TAVI-IE.

Keywords: CT; Infection; PET; valvular heart disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of patients with suspected Endocarditis based on Modified Duke Criteria, ESC criteria, and Endocarditis Team consensus based on ESC criteria
Figure 2
Figure 2
Positive results of either TTE/TEE, FDG-PET, and Cardiac CTA in each group with final diagnosis of rejected, possible, and definite TAVI-IE
Figure 3
Figure 3
Two cases of one positive PET/CT and one negative PET/CT for TAVI-IE. Case 1 (A to E): A 75-year-old female with suspected Corevalve TAVI-IE who underwent a TEE without signs of endocarditis (A to C). PET/CT images (D/E) demonstrated focal FDG uptake alongside the corevalve as positive sign of TAVI-IE. This case was previously published as a case report. Case 2 (F to I): An 81-year-old female with suspected Edwards-Sapien TAVI-IE who underwent a TEE (F/G) with a vegetation on the aortic valve and mild aortic regurgitation. CTA demonstrated thickening of the aortic valve leaflets (H) as possible signs of vegetation. However, PET/CT images (I) showed no focal 18F-FDG uptake on the leaflets. This was explained by the low inflammatory activity and 2 weeks of intravenous antibiotic therapy prior to the PET/CT scan
Figure 4
Figure 4
CTA images of a 77-year-old male with suspected TAVI-IE. Initial TEE (A, B) showed only thickened aortic valve leaflets as signs of vegetation. Repeating TEE after a few days (C, D) showed a new aortic regurgitation and a paravalvular space as sign of possible mycotic aneurysm, which was confirmed on the CTA (E)
Figure 5
Figure 5
CTA images of a Sapiens valve with signs of leaflet thrombosis (A, C, E) and a Lotus valve with signs of vegetation (B, D, F)

References

    1. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–2791. doi: 10.1093/eurheartj/ehx391. - DOI - PubMed
    1. Butt JH, Ihlemann N, De Backer O, Sondergaard L, Havers-Borgersen E, Gislason GH, et al. Long-term risk of infective endocarditis after transcatheter aortic valve replacement. J Am Coll Cardiol. 2019;73:1646–1655. doi: 10.1016/j.jacc.2018.12.078. - DOI - PubMed
    1. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM) Eur Heart J. 2015;36:3075–3128. doi: 10.1093/eurheartj/ehv319. - DOI - PubMed
    1. Saby L, Laas O, Habib G, Cammilleri S, Mancini J, Tessonnier L, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: Increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013;61:2374–2382. doi: 10.1016/j.jacc.2013.01.092. - DOI - PubMed
    1. Habets J, Symersky P, de Mol BA, Mali WP, Leiner T, Budde RP. A novel iterative reconstruction algorithm allows reduced dose multidetector-row CT imaging of mechanical prosthetic heart valves. Int J Cardiovasc Imaging. 2012;28:1567–1575. doi: 10.1007/s10554-011-9954-7. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances